NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its second-quarter revenues declined 3 percent year over year, as the diagnostics information services firm missed Wall Street estimates on the top and bottom line.

Quest had revenues of $1.82 billion for the three months ended June 30, compared to $1.88 billion for Q2 2012. It fell short of the consensus analysts' estimate of $1.84 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.